Immunoreactive SRIH was detected in the rat ovary (15.6 pg/mg wet weight, 520 pg/mg protein) and was localized to the granulosa cells (168\m=+-\6pg/106 cells). Serial dilution studies showed parallelism of the inhibition curve for synthetic and those of extracts of whole ovary and media conditioned by granulosa cells. The quantity of immunoreactive SRIH released into granulosa cell conditioned media decreased with time, while the intracellular content remained relatively constant. Gel chromatography showed peaks of immunoreactivity co-eluting with SRIH-14 (38%), SRIH-28 (31%) and a high molecular weight component. The addition of synthetic SRIH-14 stimulated meiotic maturation in cumulus-enclosed rat oocytes, with dose dependency being observed at SRIH-14 concentrations between 1 and 1000 pmol/l. No evidence of pre-pro-SRIH gene expression could be demonstrated in either rat ovary or testis using both Northern analysis and reverse transcriptase/ polymerase chain reaction amplification of polyadenylated RNA. SRIH may be produced in the ovary during a specific stage of ontogeny or by an alternative gene. It is also possible that SRIH is actively taken up and stored by granulosa cells without being produced locally.Somatostatin, initially isolated as a hypothalamic peptide regulating pituitary growth hormone secretion, has since been shown to be widely distributed both through¬ out the central nervous system (CNS) and in extraneural sites including the gut and endocrine glands where its physiological role is less well defined. Somatostatin-like immunoreactivity has been detected in the male rat (1) and human (2) reproductive systems. In the female, somatostatin-like immunoreactivity has been detected in porcine ovary (3), where it has been shown to inhibit germinal vesicle breakdown (4). In the one reported study in the rat (5), no effect of somatostatin on germinal vesicle breakdown was demonstrated, but only a small number of oocytes were studied. To our know¬ ledge, local expression of the somatostatin gene in the male or female reproductive tract has not been shown in any species. The aims of the current study were to attempt to detect somatostatin-like immunoreactivity in the rat ovary, to define its molecular forms, to determine whether the somatostatin gene is expressed in this site and to define a possible physiological role for this peptide in the ovary.
Materials and methodsAnimals/tissue samples Sexually-immature female Wistar rats (26 days old) were used in each experiment. Institutional guidelines for the care and use of laboratory animals were followed. For studies of meiotic maturation the rats were injected with 15 IU of pregnant mare's serum gonadotropin (PMSG, "Folligon", Intervet, Brussels) subcutaneously 48 h prior to being sacrificed. For RNA extraction, animals were killed by decapitation and organs rapidly removed and frozen in liquid N2. For measurement of somatostatin-like immunoreactivity organs were col¬ lected into 1 mol/I acetic acid at 0°C. For granulosa cell cultures and studies of me...